Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,253 | 264 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $962.89 | 44 | $0 (2024) |
| ABBVIE INC. | $671.63 | 36 | $0 (2024) |
| PFIZER INC. | $477.75 | 29 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $392.06 | 26 | $0 (2024) |
| Boston Scientific Corporation | $244.75 | 5 | $0 (2020) |
| SCILEX PHARMACEUTICALS INC. | $222.57 | 14 | $0 (2024) |
| Medtronic, Inc. | $206.15 | 7 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $184.96 | 11 | $0 (2022) |
| Medtronic USA, Inc. | $156.70 | 5 | $0 (2020) |
| Purdue Pharma L.P. | $151.93 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,324 | 67 | ABBVIE INC. ($299.77) |
| 2023 | $959.35 | 44 | Abbott Laboratories ($290.39) |
| 2022 | $470.41 | 26 | Biohaven Pharmaceutical Holding Company Ltd. ($184.96) |
| 2021 | $381.76 | 22 | Allergan, Inc. ($92.36) |
| 2020 | $472.46 | 28 | Abbott Laboratories ($180.24) |
| 2019 | $734.19 | 36 | Abbott Laboratories ($224.26) |
| 2018 | $271.75 | 13 | BOSTON SCIENTIFIC CORPORATION ($78.15) |
| 2017 | $638.29 | 28 | Purdue Pharma L.P. ($151.93) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 2 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.74 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: PAIN | ||||||
| 07/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.65 | General |
| Category: Opioid Analgesic | ||||||
| 07/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Neuromodulation | ||||||
| 06/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.00 | General |
| Category: Opioid Analgesic | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Sports Early Intervention | ||||||
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Gastroenterology | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: Opioid Analgesic | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: PAIN | ||||||
| 04/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: Opioid Analgesic | ||||||
| 04/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $3.16 | General |
| Category: Opioid Analgesic | ||||||
| 04/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.79 | General |
| Category: Opioid Analgesic | ||||||
| 04/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Neuromodulation | ||||||
| 03/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 450 | 1,526 | $768,325 | $118,779 |
| 2022 | 12 | 408 | 1,121 | $747,790 | $113,018 |
| 2021 | 12 | 304 | 876 | $734,600 | $110,992 |
| 2020 | 13 | 300 | 972 | $585,135 | $92,872 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 581 | $319,550 | $52,374 | 16.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 37 | 47 | $94,000 | $20,331 | 21.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 36 | 51 | $79,500 | $12,276 | 15.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 33 | 52 | $104,000 | $11,425 | 11.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 25 | 37 | $29,600 | $5,579 | 18.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 24 | 25 | $30,000 | $4,696 | 15.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 29 | 44 | $44,000 | $4,384 | 10.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 24 | 25 | $20,000 | $2,414 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $16,100 | $2,348 | 14.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 35 | $21,000 | $2,064 | 9.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 28 | 41 | $4,100 | $390.74 | 9.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 38 | 400 | $4,000 | $335.15 | 8.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 25 | $1,250 | $148.95 | 11.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 140 | $1,225 | $13.63 | 1.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 570 | $313,500 | $50,970 | 16.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 34 | 67 | $134,000 | $15,433 | 11.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 25 | 28 | $56,000 | $12,462 | 22.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 27 | 36 | $54,000 | $8,935 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $37,800 | $6,832 | 18.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 27 | 31 | $37,200 | $5,425 | 14.6% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 26 | 48 | $48,000 | $4,755 | 9.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 18 | 21 | $16,800 | $2,958 | 17.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 26 | 30 | $24,000 | $2,800 | 11.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 37 | $22,200 | $2,072 | 9.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 15 | 25 | $2,390 | $221.60 | 9.3% |
About Dr. Gonzalo Gonzales Jr., D.O
Dr. Gonzalo Gonzales Jr., D.O is a Pain Medicine healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568623890.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gonzalo Gonzales Jr., D.O has received a total of $5,253 in payments from pharmaceutical and medical device companies, with $1,324 received in 2024. These payments were reported across 264 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,253).
As a Medicare-enrolled provider, Gonzales Jr. has provided services to 1,462 Medicare beneficiaries, totaling 4,495 services with total Medicare billing of $435,661. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Plano, TX
- Active Since 06/19/2008
- Last Updated 01/29/2025
- Taxonomy Code 2081P2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568623890
Products in Payments
- BOTOX (Biological) $432.81
- XTAMPZA (Drug) $392.06
- Proclaim Family of SCS IPGs (Device) $385.57
- NURTEC ODT (Drug) $382.12
- PROCLAIM (Device) $304.63
- UBRELVY (Drug) $226.91
- INTELLIS ADAPTIVESTIM (Device) $188.41
- ZTLido (Drug) $145.22
- ETERNA (Device) $144.88
- QULIPTA (Drug) $140.37
- LYRICA (Drug) $130.05
- GENERAL THERAPIES (Device) $127.94
- RELISTOR (Drug) $125.17
- Senza Spinal Cord Stimulation System (Device) $123.39
- INTELLIS (Device) $109.77
- Movantik (Drug) $103.23
- VYEPTI (Biological) $91.18
- Horizant (Drug) $89.95
- AIMOVIG (Biological) $79.48
- GENERAL PAIN MANAGEMENT (Device) $78.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Plano
Noor Gajraj, Md, MD
Pain Medicine — Payments: $326,435
Tejas Ozarkar, Md, MD
Pain Medicine — Payments: $19,560
Dr. Sameer Syed, M.d, M.D
Pain Medicine — Payments: $18,021
Dr. Robert Nocerini, Md, MD
Pain Medicine — Payments: $7,013
Arfan Qureshi, D.o, D.O
Pain Medicine — Payments: $3,396
Robert Groysman, M.d, M.D
Pain Medicine — Payments: $2,302